mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.03 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.04 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
0.059 |
0.04 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |